Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:3032-3038
Published online before print May 28, 2002, doi: 10.1161/01.CIR.0000018745.11739.9B
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/25/3032    most recent
01.CIR.0000018745.11739.9Bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallström, S.
Right arrow Articles by Malinski, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallström, S.
Right arrow Articles by Malinski, T.
Related Collections
Right arrow CV surgery: aortic and vascular disease

(Circulation. 2002;105:3032.)
© 2002 American Heart Association, Inc.


Basic Science Reports

S-Nitroso Human Serum Albumin Treatment Reduces Ischemia/Reperfusion Injury in Skeletal Muscle via Nitric Oxide Release

Seth Hallström, PhD; Harald Gasser, MD; Christoph Neumayer, MD; Alexander Fügl, MD; Joseph Nanobashvili, MD; Andrzej Jakubowski, MD, PhD; Ihor Huk, MD; Günther Schlag, MD{dagger}; Tadeusz Malinski, PhD

From the Department of Chemistry and Biochemistry, Ohio University, Athens (S.H., A.J., T.M.); and the Ludwig Boltzmann-Institute for Experimental and Clinical Traumatology, Vienna (H.G., G.S.), and the Department of Vascular Surgery, University of Vienna (C.N., A.F., J.N., I.H.), Vienna, Austria.

Correspondence to Tadeusz Malinski, PhD, Department of Chemistry and Biochemistry, 350 W State St, Ohio University, Athens, OH 45701-2970. E-mail malinski{at}ohio.edu

Background Peroxynitrite generated from nitric oxide (NO) and superoxide (O2-) contributes to ischemia/reperfusion (I/R) injury. Feedback inhibition of endothelial NO synthase by NO may inhibit O2- production generated also by endothelial NO synthase at diminished local L-arginine concentrations accompanying I/R.

Methods and Results During hindlimb I/R (2.5 hours/2 hours), in vivo NO was monitored continuously (porphyrinic sensor), and high-energy phosphates, reduced and oxidized glutathione (chromatography), and I/R injury were measured intermittently. Rabbits receiving human serum albumin (HSA) (controls) were compared with those receiving S-nitroso human serum albumin (S-NO-HSA) beginning 30 minutes before reperfusion for 1 hour or 30 minutes before ischemia for 3.5 hours (0.1 µmol · kg-1 · h- 1). The onset of ischemia led to a rapid increase of NO from its basal level (50±12 nmol/L) to 120±20 and 220±15 nmol/L in the control and S-NO-HSA–treated groups, respectively. In control animals, NO dropped below basal levels at the end of ischemia and to undetectable levels (<1 nmol/L) during reperfusion. In S-NO-HSA–treated animals, maximal NO levels never decreased below basal concentration and on reperfusion were 100±15 nmol/L (S-NO-HSA preischemia group, 175±15 nmol/L). NO supplementation by S-NO-HSA led to partial and in the preischemia group to total preservation of high-energy phosphates and glutathione status in reperfused muscle (eg, preischemia groups: ATP, 30.23±5.02 µmol/g versus control, 15.75±4.33 µmol/g, P<0.0005; % oxidized glutathione, 4.49± 1.87% versus control, 22.84±6.39%, P<0.0001). S-NO-HSA treatment in all groups led to protection from vasoconstriction and reduced edema formation after reperfusion (eg, preischemia groups: interfiber area, 12.94±1.36% versus control, 27.83±1.95%, P< 0.00001).

Conclusions Long-lasting release of NO by S-NO-HSA provides significant protection of skeletal muscle from I/R injury.


Key Words: ischemia • reperfusion • nitric oxide • free radicals




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Hallstrom, M. Franz, H. Gasser, M. Vodrazka, S. Semsroth, U. M. Losert, M. Haisjackl, B. K. Podesser, and T. Malinski
S-nitroso human serum albumin reduces ischaemia/reperfusion injury in the pig heart after unprotected warm ischaemia
Cardiovasc Res, February 1, 2008; 77(3): 506 - 514.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Contaldo, C. Meier, A. Elsherbiny, Y. Harder, O. Trentz, M. D. Menger, and G. A. Wanner
Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H274 - H283.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Heiss, T. Lauer, A. Dejam, P. Kleinbongard, S. Hamada, T. Rassaf, S. Matern, M. Feelisch, and M. Kelm
Plasma Nitroso Compounds Are Decreased in Patients With Endothelial Dysfunction
J. Am. Coll. Cardiol., February 7, 2006; 47(3): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. S. Stamler
S-Nitrosothiols in the Blood: Roles, Amounts, and Methods of Analysis
Circ. Res., March 5, 2004; 94(4): 414 - 417.
[Full Text] [PDF]